-+ 0.00%
-+ 0.00%
-+ 0.00%
Kleiman Rajaram and Phillips & Cohen Announce Successful $46 Million Qui Tam Action Against Veloxis Pharmaceuticals
Share
Listen to the news

Veloxis Admits to Kickbacks, and to Pay Criminal Fines and Civil Penalties

BOSTON, Aug. 15, 2026 /PRNewswire/ -- In a major healthcare fraud enforcement action, Veloxis Pharmaceuticals will pay over million and accept a stringent deferred prosecution agreement after admitting illegal conduct tied to Envarsus XR in a case brought by two leading qui tam firms, Kleiman Rajaram and Phillips & Cohen.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending